The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Study enrollment to assess Feasibility
Timeframe: 16 weeks
Mean number treatment sessions attended to assess Feasibility
Timeframe: 16 weeks
Retention to assess Feasibility
Timeframe: 16 weeks
Treatment credibility to assess Acceptability
Timeframe: Week 4, Week 8, Week 12, Week 16
Treatment satisfaction to assess Acceptability
Timeframe: Week 16
Percent weight change
Timeframe: Baseline, Week 16, 6-month follow-up
Smoking cessation, as measured by exhaled carbon monoxide
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, 6-month follow-up
Smoking cessation, as measured by timeline followback interview
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, 6-month follow-up